towards improved death receptor targeted therapy for ... - TI Pharma

Chapter 6
mechanism of immune evasion of the tumor. J Cancer Res Clin Oncol 2002; 128(2):73‐79.
21. Duiker EW, Meijer A, van der Bilt AR, Meersma GJ, Kooi N, van der Zee AG et al. Drug‐
induced caspase 8 up‐regulation sensitises cisplatin‐resistant ovarian carcinoma cells to
rhTRAIL‐induced apoptosis. Br J Cancer 2011; 104(8):1278‐1287.
22. Kastan MB, Bartek J. Cell‐cycle checkpoints and cancer. Nature 2004; 432(7015):316‐323.
23. Mendoza FJ, Ishdorj G, Hu X, Gibson SB. Death receptor‐4 (DR4) expression is regulated by
transcription factor NF‐kappaB in response to etoposide treatment. Apoptosis 2008;
13(6):756‐770.
24. Frese S, Frese‐Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA. Cardiac
glycosides initiate Apo2L/TRAIL‐induced apoptosis in non‐small cell lung cancer cells by up‐
regulation of death receptors 4 and 5. Cancer Res 2006; 66(11):5867‐5874.
25. Pennarun B, Meijer A, de Vries EG, Kleibeuker JH, Kruyt F, de Jong S. Playing the DISC:
turning on TRAIL death receptor‐mediated apoptosis in cancer. Biochim Biophys Acta
2010; 1805(2):123‐140.
26. Galligan L, Longley DB, McEwan M, Wilson TR, McLaughlin K, Johnston PG. Chemotherapy
and TRAIL‐mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c‐FLIP.
Mol Cancer Ther 2005; 4(12):2026‐2036.
27. Johnston JB, Kabore AF, Strutinsky J, Hu X, Paul JT, Kropp DM et al. Role of the
TRAIL/APO2‐L death receptors in chlorambucil‐ and fludarabine‐induced apoptosis in
chronic lymphocytic leukemia. Oncogene 2003; 22(51):8356‐8369.
28. Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S et al. Expression of
apoptosis‐regulating proteins in chronic lymphocytic leukemia: correlations with In vitro
and In vivo chemoresponses. Blood 1998; 91(9):3379‐3389.
29. Ewald B, Sampath D, Plunkett W. Nucleoside analogs: molecular mechanisms signaling cell
death. Oncogene 2008; 27(50):6522‐6537.
30. Solier S, Sordet O, Kohn KW, Pommier Y. Death receptor‐induced activation of the Chk2‐
and histone H2AX‐associated DNA damage response pathways. Mol Cell Biol 2009;
29(1):68‐82.
31. Bosque A, Aguilo JI, del Rey M, Paz‐Artal E, Allende LM, Naval J et al. Cell cycle regulation
by FasL and Apo2L/TRAIL in human T‐cell blasts. Implications for autoimmune
lymphoproliferative syndromes. J Leukoc Biol 2008; 84(2):488‐498.
32. Nagaraj NS, Vigneswaran N, Zacharias W. Cathepsin B mediates TRAIL‐induced apoptosis
in oral cancer cells. J Cancer Res Clin Oncol 2006; 132(3):171‐183.
‐ 116 ‐